1.
Zheng K, Qu T, Han L, Sun Y. The role of serum BAFF, CFB, MCP-1 and anti-PLA2R antibodies in the efficacy evaluation of patients with membranous nephropathy: Serum BAFF, CFB, MCP-1 and anti-PLA2R antibodies in membranous nephropathy. J Med Biochem [Internet]. 2025 Dec. 10 [cited 2026 Jul. 12];45(6):1420-9. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/61102